- Datum30.06.2025
- Uhrzeit08:00 - 09:00 Uhr
- Veranstalter
XTB
Altan Cantürk
Moderator
TransMedics Group Inc. Aktie
Verkaufen
Kaufen
TransMedics Group Inc. Chart
TransMedics Group Inc. Realtime-Kurs
| Handelsplatz | Kurs | +/- (%) | +/- (abs) | Vortag | Zeit | Aktionen |
|---|---|---|---|---|---|---|
| L&S | VK | |||||
| Tradegate | VK | |||||
| Stuttgart | VK |
Passende Produkte
| WKN | Long/Short | KO | Hebel | Laufzeit | Bid | Ask |
|---|
Keine Ergebnisse gefunden
Wertentwicklung (Nasdaq)
1,06 %
Intraday
6,39 %
1 Woche
2,20 %
1 Monat
110,83 %
Seit Jahresbeginn
-12,73 %
1 Jahr
320,10 %
3 Jahre
683,37 %
5 Jahre
Passender Service zu TransMedics Group Inc.
Webinar zu TransMedics Group Inc.
Kursinformationen (Nasdaq)
- Tagestief / Hoch ($)-
- 52W-Tief / Hoch ($)55,000-177,370
- Jahrestief / Hoch ($)55,000-145,500
- Schlusskurs (Vortag)
- Eröffnungskurs
- Volumen Intraday
Wichtigste Eigenschaften
Dividenden von TransMedics Group Inc.
Keine Dividenden verfügbar
Termine von TransMedics Group Inc.
- Jul31TransMedics Group Inc.Q2 2025 Earnings Release
- Nov11TransMedics Group Inc.Q3 2025 Earnings Release
- Mär4TransMedics Group Inc.Q4 2025 Earnings Release
Beschreibung
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for extracorporeal perfusion and preservation of donor hearts; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.
